(Q34549725)
Statements
1 reference
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle (English)
1 reference
Wolfgang Hiddemann
1 reference
Christiane Pott
1 reference
Hannes Wandt
1 reference
Martin Dreyling
1 reference
Michael Unterhalt
1 reference
Roswitha Forstpointner
1 reference
Roland Repp
1 reference
Sandra Hermann
1 reference
Annette Hänel
1 reference
Bernd Metzner
1 reference
Frank Hartmann
1 reference
Frank Rothmann
1 reference
Robert Rohrberg
1 reference
Hans-Peter Böck
1 reference
German Low-Grade Lymphoma Study Group
1 reference
Identifiers
1 reference